lactic acid has been researched along with Meningitis, Cryptococcal in 3 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Meningitis, Cryptococcal: Meningeal inflammation produced by CRYPTOCOCCUS NEOFORMANS, an encapsulated yeast that tends to infect individuals with ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunocompromised states. The organism enters the body through the respiratory tract, but symptomatic infections are usually limited to the lungs and nervous system. The organism may also produce parenchymal brain lesions (torulomas). Clinically, the course is subacute and may feature HEADACHE; NAUSEA; PHOTOPHOBIA; focal neurologic deficits; SEIZURES; cranial neuropathies; and HYDROCEPHALUS. (From Adams et al., Principles of Neurology, 6th ed, pp721-2)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The optimal dosage of fluconazole and the impact of combination with flucytosine are not known." | 1.29 | Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome. ( Elliott, BR; Kartalija, M; Kaye, K; Liu, Q; Sande, MA; Täuber, MG; Tureen, JH, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abassi, M | 1 |
| Bangdiwala, AS | 1 |
| Nuwagira, E | 1 |
| Kandole Tadeo, K | 1 |
| Okirwoth, M | 1 |
| Williams, DA | 1 |
| Mpoza, E | 1 |
| Tugume, L | 1 |
| Ssebambulidde, K | 1 |
| Huppler Hullsiek, K | 1 |
| Musubire, AK | 1 |
| Muzoora, C | 1 |
| Rhein, J | 1 |
| Meya, DB | 1 |
| Boulware, DR | 1 |
| Tsai, WC | 1 |
| Lien, CY | 1 |
| Lee, JJ | 1 |
| Huang, CR | 1 |
| Tsai, NW | 1 |
| Chang, CC | 1 |
| Lu, CH | 1 |
| Chang, WN | 1 |
| Kartalija, M | 1 |
| Kaye, K | 1 |
| Tureen, JH | 1 |
| Liu, Q | 1 |
| Täuber, MG | 1 |
| Elliott, BR | 1 |
| Sande, MA | 1 |
3 other studies available for lactic acid and Meningitis, Cryptococcal
| Article | Year |
|---|---|
Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis.
Topics: Cerebrospinal Fluid; Cryptococcus; Humans; Lactic Acid; Meningitis, Cryptococcal; Prognosis; Severit | 2021 |
The clinical characteristics of adult cryptococcal meningitis patients who died within one year of treatment with a focus on those with early mortality.
Topics: Adult; Aged; Aged, 80 and over; Female; Fungemia; Humans; Lactic Acid; Male; Meningitis, Cryptococca | 2019 |
Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome.
Topics: Animals; Antifungal Agents; Antigens, Fungal; Brain Edema; Cryptococcus neoformans; Drug Therapy, Co | 1996 |